Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma.

about

Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab.

P2860

Q55518414-C5A3031B-789B-49EC-868F-384E3563827A

P2860

Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma.

Item

http://www.wikidata.org/entity/Q55286218

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Exploratory pooled analysis ev ...... tastatic colorectal carcinoma.

@en

Exploratory pooled analysis ev ...... tastatic colorectal carcinoma.

@nl

type

Item

label

Exploratory pooled analysis ev ...... tastatic colorectal carcinoma.

@en

Exploratory pooled analysis ev ...... tastatic colorectal carcinoma.

@nl

prefLabel

Exploratory pooled analysis ev ...... tastatic colorectal carcinoma.

@en

Exploratory pooled analysis ev ...... tastatic colorectal carcinoma.

@nl

P1476

Exploratory pooled analysis ev ...... etastatic colorectal carcinoma

@en

P2093

Alberto Zaniboni

http://www.w3.org/2001/XMLSchema#string

Fernando Rivera

http://www.w3.org/2001/XMLSchema#string

Frédéric Forget

http://www.w3.org/2001/XMLSchema#string

Gaston Demonty

http://www.w3.org/2001/XMLSchema#string

Manuel Valladares-Ayerbes

http://www.w3.org/2001/XMLSchema#string

Meinolf Karthaus

http://www.w3.org/2001/XMLSchema#string

Xuesong Guan

http://www.w3.org/2001/XMLSchema#string

P2860

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type metastatic colorectal cancer.

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.

Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.

Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.

PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic color

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, doubl

P304

e000297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ESMOOPEN-2017-000297

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marc Peeters

P577

2018-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29531837

http://www.w3.org/2001/XMLSchema#string

P932

5844379

http://www.w3.org/2001/XMLSchema#string

Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma.

about

P2860

P2860

Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932